Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of CLN-978 in autoimmune ...

The good folks over at Atlanta, Georgia-based Road Show International, have a 'subtle' treat that may or may not cause fans ...

VAN NUYS — A fundraising effort is continuing in support of two 22-year-old men and church volunteers whose car was struck by ...

Police in Cullinan arrested a 46-year-old man in possession of ammunition and drugs on Saturday. Police spokesperson Sergeant ...

Global Phase 1 study of CLN-978 in systemic lupus erythematosus (SLE) cleared to initiate in U.S. and Australia; initial ...

Collisions involving two speeding cars, two other vehicles and a hit-and-run left two victims severely injured in Van Nuys on ...

Jacques addresses the significance of the astounding Lucara Diamond recently discovered, and GIA's work helping dealers, ...

This 2025 Rolls-Royce Cullinan features new wheels that Novitec and Vossen co-developed. Is it the luxury SUV of your dreams?

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Cullinan Management (CGEM – Research Report). The associated ...

Whether you love or hate the Rolls-Royce Cullinan and everything it stands for, there’s no denying its success. So, will the ...

Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted ...

CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today ...